Table 2.

Overall ureteral stent in situ-related symptoms

Domains	Items	Scores		Standard deviation		P
		String	No string	String	No string
Urinary symptoms	Domain total	30.6	28.2	8.54	7.25	0.17*
	Daytime frequency	3.02	3.37	1.14	1.25	0.17*
	Nocturia	2.58	2.40	1.07	1.30	0.48*
	Urgency	2.21	1.97	1.01	1.11	0.31*
	Urge incontinence	1.42	1.33	0.63	0.82	0.59*
	Non urge incontinence	1.37	1.16	0.72	0.63	0.14*
	Residual urine sensation	3.02	2.60	1.18	1.29	0.11*
	Dysuria	2.95	2.36	1.53	1.05	0.03*
	Hematuria frequency	3.12	2.80	1.61	1.27	0.31*
	Hematuria amount	2.32	2.29	1.06	0.87	0.86*
	Interference in life	2.81	2.44	1.31	1.12	0.16*
	Quality of life impact	5.76	5.51	1.50	1.31	0.40*
Pain	Domain total	21.02	20.40	6.39	5.38	0.62*
	Presence or absence of pain	1.23	1.16	0.43	0.37	0.39*
	VAS	6.27	5.71	2.84	2.90	0.36*
	Pain associated with amount of physical activities	3.20	3.02	1.25	1.32	0.50*
	Sleep disturbance	2.20	2.13	1.10	1.04	0.74*
	Pain at voiding	3.33	3.09	1.24	1.04	0.34*
	Flank pain at voiding	1.37	1.47	0.49	0.50	0.37*
	Frequency of painkiller	2.16	2	1.13	0.93	0.46*
	Overall bother	3.05	2.84	1.31	1.04	0.42*
General health	Domain total	15.12	14.04	5.97	5.09	0.37*
	Difficulties with light physical activity	2.23	1.91	1.36	0.99	0.20*
	Difficulties with heavy physical activity	2.77	2.18	1.46	1.21	0.04*
	Feeling tired	2.33	2.4	1.21	1.18	0.77*
	Feeling calm and peaceful	3.40	3.53	1.43	1.42	0.65*
	Social life enjoyment	2.88	2.62	1.33	1.34	0.36*
	Need extra help	1.51	1.4	0.91	0.86	0.56*
Work performance	Domain total	14.41	15.6	6.32	7.04	0.41*
	Type of employment	2.30	3.31	2.22	2.65	0.06*
	Number of days bed rest all day long	1.79	1.47	2.73	2.30	0.55*
	Number of days reduced more than half daily activity	1.80	2.24	1.80	2.64	0.30*
	Position or role in workplace	1.81	1.75	0.93	0.84	0.74*
	Frequency of rest	1.98	1.08	2.44	1.22	0.06*
	Stent related changes on work	2.28	1.98	1.22	1.05	0.22*
	Changes in work duration	2.51	2.44	1.45	1.27	0.82*
Sexual matters
	No active sexual life: n (%)	42(97.6)	38(82.6)	-	-	0.02**
	Stop of sexual Intercourse after stent: n (%)	22(52)	18(47.3)	-	-	0.82**
	Stop of sexual intercourse due to stent-related problem: n (%)	17(77)	8(44.4)	-	-	0.03**
Additional problems	Need for additional antibiotics (%)	0	0	-	-	-
	Admission or additional therapeutic procedure(%)	0	0	-	-	-

* Student’s t-test, ** χ² test.